Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · IEX Real-Time Price · USD
47.10
-0.41 (-0.86%)
At close: May 17, 2024, 4:00 PM
48.05
+0.95 (2.02%)
After-hours: May 17, 2024, 5:44 PM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $2.45 billion as of May 17, 2024. Its market cap has increased by 350.01% in one year.
Market Cap
2.45B
Enterprise Value
1.82B
1-Year Change
350.01%
Ranking
Category
Stock Price
$47.10
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $2.45B, an increase of 299.11%. That is a compound annual growth rate of 60.27%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 2.44B | -0.86% |
May 16, 2024 | 2.46B | 0.06% |
May 15, 2024 | 2.46B | -0.90% |
May 14, 2024 | 2.48B | -4.16% |
May 13, 2024 | 2.59B | 2.19% |
May 10, 2024 | 2.54B | -5.81% |
May 9, 2024 | 2.69B | -6.20% |
May 8, 2024 | 2.87B | -9.63% |
May 7, 2024 | 3.18B | -1.11% |
May 6, 2024 | 3.21B | -4.00% |
May 3, 2024 | 3.35B | 3.76% |
May 2, 2024 | 3.23B | 7.29% |
May 1, 2024 | 3.01B | 2.09% |
Apr 30, 2024 | 2.94B | 1.64% |
Apr 29, 2024 | 2.90B | 18.34% |
Apr 26, 2024 | 2.45B | 0.62% |
Apr 25, 2024 | 2.43B | -2.30% |
Apr 24, 2024 | 2.49B | -3.15% |
Apr 23, 2024 | 2.57B | 1.84% |
Apr 22, 2024 | 2.53B | 0.39% |
Apr 19, 2024 | 2.52B | -0.33% |
Apr 18, 2024 | 2.52B | 1.86% |
Apr 17, 2024 | 2.48B | -5.12% |
Apr 16, 2024 | 2.61B | -2.53% |
Apr 15, 2024 | 2.68B | -1.50% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ICU Medical | 2.56B |
MoonLake Immunotherapeutics | 2.55B |
Intellia Therapeutics | 2.52B |
Fortrea Holdings | 2.50B |
ACADIA Pharmaceuticals | 2.46B |
RxSight | 2.43B |
Rhythm Pharmaceuticals | 2.40B |
NovoCure | 2.35B |